A weekly roundup of healthcare investigations ...

What if a new combination of cancer drugs could sound an alarm, alerting the body's immune system to invoke a targeted ...

A series of five papers, published today in The Lancet Oncology by a University of Pittsburgh-led international team, highlights critical public health challenges related to cancer control in the ...

Officials at Dana-Farber Cancer Institute are moving to retract at least six published research papers and correct 31 others amid allegations of data manipulation. News of the investigation follows a ...

Despite several randomized controlled trials demonstrating the benefits of combination therapies for metastatic hormone-sensitive prostate cancer (mHSPC), a significant treatment gap persists. This ...

Add Yahoo as a preferred source to see more of our stories on Google. The Dana-Farber Cancer Institute has requested the retraction of six studies and corrections in another 31 papers after a scathing ...

Scientists have identified proteins that could signal increased lung cancer risk, as well as a drug that could reduce the ...

The first quarter of the twenty-first century has produced some huge scientific breakthroughs, ranging from the first mRNA vaccines and CRISPR-based gene-editing techniques to the discovery of the ...

The results of a study in mice by Van Andel Institute (VAI) scientists suggest that a person’s lifetime risk for cancer may begin before they are even born. Headed by J. Andrew Pospisilik, PhD, chair ...

South Asian Association for Regional Cooperation (SAARC) countries — Afghanistan, Bangladesh, Bhutan, India, the Maldives, Nepal, Pakistan and Sri Lanka — are shown in blue. The papers call for a ...